Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies and settings. For example,…
Read more
Pharmaceutical companies spend more than $5 billion on patient support programs each year, but only 3 percent of patients actually use them. So what gives? What does an effective patient support program look like, and…
Read more
The patient journey is paramount in healthcare today. Newly emerging technologies, shifting industry dynamics, and evolving consumer preferences are reshaping what the modern patient experience should look like. That’s why more and more healthcare organizations…
Read more
These days, nearly everything is driven by data in one way or another. Data empowers us to make better, more strategic decisions in many areas of life. Now, we are seeing more and more how…
Read more
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of…
Read more
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses…
Read more
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play…
Read more
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at…
Read more
Pharmacies can use artificial intelligence to make adherence improvements that meet the goals of their payer contracts, specifically the ones known as DIR (direct and indirect remuneration). When it comes to getting reimbursements, adherence plays…
Read more